Novel Device to Assess Endotracheal Tube Migration

May 12, 2025 updated by: Adriano Tonelli, The Cleveland Clinic

Novel Device (AirWave™) to Assess Endotracheal Tube Migration.

To evaluate the ability of the SonarMed AirWave to provide clinicians with information that enables them to confirm continuous proper placement of the endotracheal tube. This initial study is prospective, observational, looking at CXR results, and comparing those to AirWave system output data.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

42

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cleveland, Ohio, United States, 44195
        • Cleveland Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

MICU Based

Description

Inclusion Criteria

Subjects will be eligible for inclusion in the study if they meet ALL of the following criteria:

  • Oral or nasal endotracheal intubation, anticipated to last at least 48 hours
  • Adults that require ETT internal diameter sizes of 6.5 - 9.0 mm
  • Subject must be at least 18 years old (no upper age limitation)
  • English speaking patients/decision makers.

Exclusion Criteria

  • Subjects ventilated through a tracheostomy
  • Subjects under 18 years of age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Oral or nasal endotracheal intubation
Oral or nasal endotracheal intubation, anticipated to last at least 48 hours Adults that require ETT internal diameter sizes of 6.5 - 9.0 mm Subject must be at least 18 years old (no upper age limitation) English speaking patients/decision makers.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Endotracheal Tube Displacement Bias Measured by a Novel Device (AirWave) Compared to CXR
Time Frame: 24 hours
Comparison of migration at 24 hours as measured by the AirWave system and portable CXR using a Bland-Altman analysis.
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adriano Tonelli, MD, The Cleveland Clinic Foundatin

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2012

Primary Completion (Actual)

June 1, 2012

Study Completion (Actual)

June 1, 2012

Study Registration Dates

First Submitted

September 21, 2012

First Submitted That Met QC Criteria

September 28, 2012

First Posted (Estimated)

October 2, 2012

Study Record Updates

Last Update Posted (Actual)

May 14, 2025

Last Update Submitted That Met QC Criteria

May 12, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 111128-PIP

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mechanically Ventilated Patients Admitted to a MICU

Clinical Trials on AirWave

Subscribe